Organization Overview
aldesleukin (Proleukin) (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
allogeneic natural killer cells (2 trials)
autologous hematopoietic stem cells (1 trial)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (2 trials)
dinutuximab (unituxin) (1 trial)
etoposide (vepesid) (2 trials)
Histiocytosis (Phase 2)
Histiocytosis, Langerhans-Cell (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lymphoma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neuroblastoma (Phase 2)